Ronald Dorenbos Email and Phone Number
Ronald Dorenbos work email
- Valid
- Valid
Ronald Dorenbos personal email
- Valid
A strategist and innovation leader who is creative and, passionate about leading cross-functional teams, identifying innovative opportunities and helping individuals and organizations perform at their best. Skilled in driving innovation, identifying out-of-the-box opportunities, and bringing positive energy to diverse projects. • Delivered the digital strategy for a global pharma operating in over 90 countries• Turned around an underperforming oncology asset for one of the world’s top 10 Pharmas• Keynote speaker at international events on topics related to Artificial Intelligence, Pharma, Healthcare, Innovation and Scouting • Extensive, global academic and industry network
-
Founder And Managing DirectorBiofrontlineBoston, Ma, Us
-
Vice President Business DevelopmentEvotec Apr 2024 - PresentHamburg, DeEvotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter. -
PrincipalBiofrontline 2011 - PresentBelmont, Massachusetts, UsDriving innovation in the pharma industry.
-
AdvisorStemcultures, Llc. Mar 2024 - Oct 2024Rensselaer, New York, UsStemCultures has found a way to maintain control over stem cell growth factor levels. Now you can orchestrate culture conditions for higher quality cells while saving time and money. -
AdvisorResolutum Global Pty Ltd Feb 2024 - Jul 2024Melbourne, Vic, AuResolutum Global is a clinical research organization (CRO) based in Australia that specializes in providing biometrics services for early phase and medical device clinical trials. As a data-focused biometrics CRO, Resolutum Global is primarily focused on data capture, data analysis, and reporting. -
Business Development ConsultantEnginzyme Oct 2023 - Jul 2024Solna, Solna, SeEnginZyme is a Swedish startup with the vision to make the chemical industry green by unlocking the potential in enzymes. EnginZyme's cell-free biomanufacturing platform is created through a best-in-class approach that combines the breadth and power of biology and the efficiencies of the chemical industry. By replacing traditional fossil-based manufacturing with a cell-free technology platform, EnginZyme seeks to play a key role in solving one of the fundamental challenges of our time – how to produce better, greener, and cheaper products that we use every day. -
AdvisorVincere Biosciences Mar 2024 - Jun 2024Cambridge, Massachusetts, UsAt Vincere Biosciences, cutting-edge research focuses on the vital role of mitophagy in both Parkinson's disease and the aging process. By addressing deficient mitophagy, Vincere can usher in a new era of groundbreaking treatments.Vincere's innovative pipeline consists of small molecules designed to boost mitophagy, with the potential to become the first-ever medicines capable of slowing or stopping Parkinson's disease and other age-related conditions.By harnessing the power of advanced research, Vincere Biosciences aims to bring hope and transform the lives of those affected by these debilitating diseases. -
AdvisorTerra Bioforge Jan 2024 - Jun 2024Terra Bioforge is leveraging a portfolio of breakthrough proprietary tools andtechnology assets to scale production of microbial natural products faster and more efficiently. -
AdvisorBentley University Nov 2023 - Jun 2024Waltham, Massachusetts, UsAdvising Center for Health & Business on their AI in Life Sciences program. -
AdvisorStealth Mode Biotech Jan 2023 - Apr 2024
-
Executive Director Business Development, LogicaCharles River Laboratories Jun 2022 - May 2023Wilmington, Massachusetts, UsCharles River Laboratories and Valo Health launched Logica, an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets. Logica leverages Valo’s AI-powered Opal Computational Platform and Charles River’s leading preclinical expertise, providing clients with transformed drug discovery with a single integrated offering seamlessly translating targets to candidate nomination. Feel free to connect to learn more about the way that AI-powered solutions can drive drug discovery forward to bring effective treatments to patients faster. Looking forward to being in touch. -
Senior Director Strategy & CollaborationsSanofi Mar 2021 - Dec 2021Paris, France, Fr -
Head Innovation Management & ScoutingTakeda 2019 - 2020Tokyo, Jp* Identified and implemented new technologies and innovation across Takeda. * Structured deals and managed collaborations between Takeda and academic and industry partners. -
Associate Director Materials & InnovationTakeda 2017 - 2019Tokyo, JpStrengthening Takeda's pipeline with novel products and innovative technologies.
-
Life Science Strategy Consulting And CommercializationPa Consulting Group 2015 - 2017London, London, GbPA is a leading consulting, technology and innovation firm of over 2,500 people, operating globally from offices across North America, Europe, the Nordics, the Gulf and Asia Pacific. Its specific expertise is in energy and utilities, financial services, health, life sciences, consumer and manufacturing, government, defense and security, transport and logistics. In 2015, Carlyle Group bought 51% of the company and valued PA at $1B. -
Business DevelopmentCyclofluidic Ltd. 2013 - 2015Cyclofluidic is a technology company founded by UCB and Pfizer and supported by the UK Technology Strategy Board (TSB) with the goal of improving the efficiency of drug discovery through the integration of chemistry and biology. The company uses an integrated microfluidic platform that combines both chemical synthesis and biological assay to rapidly deliver high quality molecules and data to feed the drug development pipeline.
-
Strategy And Project ManagementRxi Pharmaceuticals Corporation 2010 - 2012Led collaboration between RXi & UMass to develop RNAi-based drugs for ALS (Lou Gehrig's Disease)
-
Postdoctoral FellowHarvard Medical School 2004 - 2010Boston, Ma, UsLeading international collaborations between cross-functional teams doing research on Parkinson's Disease, Schizophrenia and the genetic basis of aggression.
Ronald Dorenbos Skills
Ronald Dorenbos Education Details
-
Harvard UniversityChinese -
University Of GroningenPharmaceutical Biology
-
University Of GroningenMolecular Biology
-
HanzeBiotechnology
Frequently Asked Questions about Ronald Dorenbos
What company does Ronald Dorenbos work for?
Ronald Dorenbos works for Biofrontline
What is Ronald Dorenbos's role at the current company?
Ronald Dorenbos's current role is Founder and Managing Director.
What is Ronald Dorenbos's email address?
Ronald Dorenbos's email address is ro****@****ail.com
What schools did Ronald Dorenbos attend?
Ronald Dorenbos attended Harvard University, University Of Groningen, University Of Groningen, Hanze.
What are some of Ronald Dorenbos's interests?
Ronald Dorenbos has interest in Photography, Science, Music, Art.
What skills is Ronald Dorenbos known for?
Ronald Dorenbos has skills like Biotechnology, Molecular Biology, Drug Discovery, Pharmaceutical Industry, Strategy, Drug Development, Cell Biology, Neuroscience, Microbiology, Biochemistry, Science, Infectious Diseases.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial